Abstract 3247: Genome-wide cell-free DNA mutation integration for sensitive cancer detection

Solid malignancies are often diagnosed at a late stage with dismal prognosis. Even after cancer is diagnosed, we lack sensitive tools to guide difficult therapeutic decisions such as adjuvant therapy. Sensitive cancer detection by blood biopsy can therefore transform care by enabling early detection and residual disease monitoring. Cell free DNA mutation detection has shown significant promise in its ability to survey the somatic genome and...